Trial Profile
Phase 3 Efficacy and Safety Study of ACC007 Combined with 3TC+TDF in the Treatment of HIV/AIDS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2019
Price :
$35
*
At a glance
- Drugs Ainuovirine (Primary) ; Efavirenz (Primary) ; Lamivudine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV-1 infections
- Focus Registrational; Therapeutic Use
- Sponsors Jiangsu Aidea Pharmaceutical
- 30 Oct 2018 New trial record